Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corticosteroid Therapy and Long-Term Outcomes of Post-Infectious Inflammatory Syndrome in Non-HIV Immunosuppressed Cryptococcal Meningitis: A Multicenter Case Series.

The Journal of infectious diseases·2026
Same author

Cerebral Venous Thrombosis in Previously Healthy Patients with Cryptococcal Meningitis.

The Journal of infectious diseases·2025
Same author

Target product profile and discovery and development path for novel cryptococcal disease treatments.

The Journal of infection·2025
Same author

mGem: When immunity turns against itself-GM-CSF autoantibodies drive opportunistic infection risk.

mBio·2025
Same author

Adrenal Corticosteroids and Increased Intracranial Pressure in Nonimmunocompromised Patients With Cryptococcal Meningitis.

The Journal of infectious diseases·2025
Same author

Peripheral blood CD4<sup>+</sup> and CD8<sup>+</sup> T cell responses to Cryptococcus candidate vaccine antigens in human subjects with and without cryptococcosis.

The Journal of infection·2025
Same journal

Diverse genetic lineages spreading across healthcare and community boundaries underlie extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) colonization burden in Botswana.

The Journal of infectious diseases·2026
Same journal

Retraction of: Tracking Plasmodium knowlesi Through Fecal DNA for Monitoring Zoonotic Transmission in Wild Macaques Across Southeast and South Asia.

The Journal of infectious diseases·2026
Same journal

Can malaria induce loss of vaccine immunity.

The Journal of infectious diseases·2026
Same journal

NET-inducing ability of Cutibacterium acnes clinical isolates is associated with pathogenicity in acne vulgaris.

The Journal of infectious diseases·2026
Same journal

Optimizing the Use of Proviral DNA HIV Drug Resistance Testing: Clinical Applications and Cautions.

The Journal of infectious diseases·2026
Same journal

Monitoring HLA-A2-restricted T cell responses and BCLA-specific serostatus during human latent Toxoplasma gondii infection suggests the implication of CD8+ T cells in parasite containment.

The Journal of infectious diseases·2026
See all related articles

Related Experiment Video

Updated: Jun 21, 2025

Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans
08:24

Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans

Published on: February 27, 2018

13.9K

Antigen Titers in Cryptococcal Meningitis: What Determines How Fast They Fall?

John E Bennett1, Peter R Williamson1

  • 1Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland.

The Journal of Infectious Diseases
|July 10, 2024
PubMed
Summary
This summary is machine-generated.

Cryptococcal antigen persists for over a year in serum and cerebrospinal fluid (CSF) after meningitis. Factors like Cryptococcus species and shunting significantly slow antigen clearance in survivors.

Keywords:
antigencerebrospinal fluidcryptococcosispolysaccharideventriculoperitoneal shunt

More Related Videos

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.3K
A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms
06:50

A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms

Published on: September 16, 2022

3.1K

Related Experiment Videos

Last Updated: Jun 21, 2025

Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans
08:24

Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans

Published on: February 27, 2018

13.9K
Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.3K
A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms
06:50

A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms

Published on: September 16, 2022

3.1K

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Neurology

Background:

  • Cryptococcal meningitis is a serious infection, particularly in immunocompromised individuals.
  • Long-term follow-up of survivors is crucial to understand disease persistence and potential complications.
  • Detection of cryptococcal antigen beyond clinical resolution is not well-characterized.

Purpose of the Study:

  • To investigate the duration and kinetics of cryptococcal antigen detection in serum and cerebrospinal fluid (CSF) in patients who survived cryptococcal meningitis.
  • To identify factors influencing the rate of antigen titer decline.

Main Methods:

  • Prospective follow-up study of patients recovering from cryptococcal meningitis.
  • Serial measurement of cryptococcal antigen titers in serum and CSF.
  • Analysis of antigen titer decline rates and correlation with species and treatment interventions.

Main Results:

  • Cryptococcal antigen was detectable for over a year in 86% of serum samples and 67% of CSF samples, long after culture conversion.
  • Antigen titer decline was slower in serum than in CSF.
  • Clearance was significantly slower in patients infected with Cryptococcus gattii compared to Cryptococcus neoformans.
  • Patients with ventriculoperitoneal shunts exhibited slower antigen titer decline in both serum and CSF.

Conclusions:

  • Cryptococcal antigen can remain detectable for extended periods post-treatment, irrespective of clinical recovery.
  • The rate of antigen clearance is influenced by the infecting Cryptococcus species and the presence of a ventriculoperitoneal shunt.
  • These findings highlight the complex dynamics of cryptococcal antigen persistence and underscore the need for further research into their clinical significance.